JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265153

Human LTB4R2 (Leukotriene B4 Receptor 2) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

LTB4R2 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 22 bp deletion in exon 2. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Sanger Sequencing - Human LTB4R2 (Leukotriene B4 Receptor 2) knockout HeLa cell line (AB265153)
  • Sanger seq

Unknown

Sanger Sequencing - Human LTB4R2 (Leukotriene B4 Receptor 2) knockout HeLa cell line (AB265153)

Homozygous : 22 bp deletion in exon 2.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 22 bp deletion in exon 2

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265153-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265153-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265153 Human LTB4R2 (Leukotriene B4 Receptor 2) knockout HeLa cell line", "number":"AB265153-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265153-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265153-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265153 Human LTB4R2 (Leukotriene B4 Receptor 2) knockout HeLa cell line", "number":"AB265153-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265153-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265153 Human LTB4R2 (Leukotriene B4 Receptor 2) knockout HeLa cell line", "number":"AB265153-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265153-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265153 Human LTB4R2 (Leukotriene B4 Receptor 2) knockout HeLa cell line", "number":"AB265153-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
LTB4R2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Leukotriene B4 Receptor 2 (BLT2) also known as LTB4R2 plays an important mechanical role as a G-protein coupled receptor (GPCR) that binds leukotriene B4 (LTB4) a pro-inflammatory lipid mediator. BLT2 has a molecular mass of approximately 41 kDa and exhibits expression notably in tissues such as the spleen liver and intestinal tract. Alternative names for this receptor include BLTR2 or GPR43. It functions as part of the rapid cellular response in these tissues during immune reactions.
Biological function summary

The receptor BLT2 significantly contributes to the regulation of inflammatory responses. This receptor does not form part of a functional complex but operates independently to mediate chemotaxis and aggregation of immune cells like neutrophils. By interacting with leukotriene B4 BLT2 facilitates diverse immune responses including leukocyte recruitment and activation. Such activities underline its importance in acute inflammatory reactions and pathogen defense mechanisms.

Pathways

BLT2 influences and integrates into key cellular signaling routes such as the MAPK/ERK and PI3K/Akt pathways. These pathways affect cellular processes like proliferation survival and differentiation. BLT2's interaction with proteins involved in these pathways like ERK (Extracellular Signal-Regulated Kinases) or Akt (protein kinase B) demonstrate its role in amplifying and regulating immune responses during prolonged inflammation.

BLT2 has associations with inflammatory diseases including asthma and rheumatoid arthritis. These conditions involve chronic inflammation where BLT2 together with proteins like cytokines and other chemoattractant receptors exacerbates cellular recruitment and inflammatory signaling. By linking hyperactive immune cell responses BLT2 serves as a potential target in moderating disease manifestations and developing anti-inflammatory leukotriene-based therapies.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com